Foghorn Therapeutics Inc. (31) | Business Operations (3)

Browse by Subcategory

Recent Contracts

Amendment to the Investors Rights Agreement and the Voting Agreement, dated December 18, 2018, by and among Foghorn Therapeutics Inc. and the investors party thereto, dated as of... (Filed With SEC on October 2, 2020)
Exclusive Collaboration and License Agreement, by and between Merck Sharp & Dohme Corp. and Foghorn Therapeutics Inc., dated as of July 2, 2020 (Filed With SEC on October 2, 2020)
Form of Indemnification Agreement between Foghorn Therapeutics Inc. and its directors and officers (Filed With SEC on October 2, 2020)